November 15, 2023

Press Release: ECOG-ACRIN and PrECOG announce multiple presentations at ASH 2023

November 7, 2023

ECOG-ACRIN Group Co-Chairs congratulate Dr. Monica Bertagnolli on her appointment as Director of the National Institutes of Health

July 20, 2023

Press Release: ECOG-ACRIN adds a new treatment trial to the ComboMATCH precision medicine initiative

February 27, 2023

The TAILORx trial continues to provide reassurance that many women with early breast cancer can safely forego chemotherapy

February 23, 2023

A focus on the DREAMseq trial reveals data-driven clinical insights into the selection of first-line treatment options for patients with BRAF-mutated metastatic melanoma

February 15, 2023

A participant in the E1910 trial shares her experience in a Penn Medicine feature story with her hematologist, Dr. Selina Luger

February 15, 2023

ASCO Living Guideline says ‘no’ to anti-VEGF-chemo combo in non-small cell lung cancer without driver alterations, based on data from the E5508 trial

February 10, 2023

ECOG-ACRIN announces the Remarkable Mentor to Women in Oncology Award (nominations are due March 9)

February 9, 2023

The application period is now open for Spring Meeting Attendance Awards for minority trainees

ECOG-ACRIN Cancer Research Group